A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants | MicrobiomeTrials← Back to trialsNCT07727538
A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-07Est. Completion: 2030-08
Enrollment target: 12 participants Locations- University of Texas Southwestern Medical Center, Dallas, Texas, United States
Other microbiome trials you might be interested in
Type 1 Hyperlipoprotenemia
Type I hyperlipoproteinemia (T1HLP, also known as familial chylomicronemia syndrome or FCS) is a rare diseasewhere the b…
Dallas, United StatesEst. completion Aug 1, 2027
Familial Chylomicronemia
The purpose of AROAPOC3-3001 is to evaluate the efficacy and safety of ARO-APOC3 (plozasiran) in adult participants with…
Boca Raton, United StatesCompleted Apr 29, 2024